BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21061788)

  • 1. Follow-up in a long-term randomized trial with neoadjuvant chemotherapy for squamous cell cervical carcinoma.
    Mossa B; Mossa S; Corosu L; Marziani R
    Eur J Gynaecol Oncol; 2010; 31(5):497-503. PubMed ID: 21061788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial.
    Napolitano U; Imperato F; Mossa B; Framarino ML; Marziani R; Marzetti L
    Eur J Gynaecol Oncol; 2003; 24(1):51-9. PubMed ID: 12691318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results.
    Sardi JE; Giaroli A; Sananes C; Ferreira M; Soderini A; Bermudez A; Snaidas L; Vighi S; Gomez Rueda N; di Paola G
    Gynecol Oncol; 1997 Oct; 67(1):61-9. PubMed ID: 9345358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
    Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
    Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.
    Benedetti-Panici P; Greggi S; Scambia G; Amoroso M; Salerno MG; Maneschi F; Cutillo G; Paratore MP; Scorpiglione N; Mancuso S
    Eur J Cancer; 1998 Feb; 34(3):341-6. PubMed ID: 9640219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer.
    Chang TC; Lai CH; Hong JH; Hsueh S; Huang KG; Chou HH; Tseng CJ; Tsai CS; Chang JT; Lin CT; Chang HH; Chao PJ; Ng KK; Tang SG; Soong YK
    J Clin Oncol; 2000 Apr; 18(8):1740-7. PubMed ID: 10764435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of the cervix: results and prognostic variables.
    Seoud M; Geara FB; Shamseddine A; Salem Z; Khalil A
    Eur J Gynaecol Oncol; 2003; 24(2):163-8. PubMed ID: 12701970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix.
    Sardi J; Sananes C; Giaroli A; Bayo J; Rueda NG; Vighi S; Guardado N; Paniceres G; Snaidas L; Vico C
    Gynecol Oncol; 1993 May; 49(2):156-65. PubMed ID: 7684993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>/=4 cm) stage IB and IIA cervical carcinoma.
    Huang HJ; Chang TC; Hong JH; Tseng CJ; Chou HH; Huang KG; Lai CH
    Int J Gynecol Cancer; 2003; 13(2):204-11. PubMed ID: 12657125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.
    Qin T; Zhen J; Zhou M; Wu H; Ren R; Qu B; Wang H
    Int J Surg; 2016 Jun; 30():121-5. PubMed ID: 27131759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer.
    Behtash N; Nazari Z; Ayatollahi H; Modarres M; Ghaemmaghami F; Mousavi A
    Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma.
    Chang HC; Lai CH; Chou PC; Tseng CJ; Chang TC; Hsueh S; Ho YS; Soong YK
    Cancer Chemother Pharmacol; 1992; 30(4):281-5. PubMed ID: 1379522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.